Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 4 November 2026.
Announcements
6,263
Total raised
£165B
disclosed amounts
This month
£177M
raised so far
The follow-on investment will support international expansion and product development.
"We’re thrilled that Downing Ventures has decided to back us in our next chapter. The Downing team offers a lot more than just funding and their expertise in the sector will provide a value-add that will really accelerate our service. With this new funding, we’ll be able to lean into our goal of internationalising and developing our products and communities."
The Series C financing was led by Sofina with participation from EQT Ventures and Balderton Capital.
"The vast majority of Gen Zers in the US are living from paycheque to paycheque. It’s harder than ever for them to get ahead – particularly as the price of everything continues to increase – and yet this audience continues to be neglected, or worse, exploited, by the traditional financial services industry."
The seed round was led by Love Ventures with participation from Concrete Ventures and industry angels.
"Having developed a unique market-leading solution for the commercial property leasing process, we felt that the size of the opportunity to expand into new sectors and geographies warranted an influx of capital. In Love Ventures, Concrete Ventures and multiple industry-leading angels, we have got passionate, smart and supportive partners who we are thrilled to welcome aboard for the next phase of our journey."
Archangels led the financing round to support the development of the company cell analysis platform.
"On behalf of our Board and employees I would like to thank our investors for their continued support of Cytomos. We now have the growth capital required to advance the development of our novel process analytical technology platform to the next phase of prototype evaluation with our strategic partners. This is an important milestone in the journey to deliver our mission to enable the development and manufacture of life saving biologic therapies"
The financing round was backed by investors including Elkstone Capital, SciFounders, and Faber.
"Our mission is to revolutionise the user experience of healthcare. We do that by building medical devices with a patient-first approach, and focusing on the needs that truly matter to patients. This funding round will allow us to complete first in patient clinical trials of our innovative Lily Device, and accelerate our path to market launch and patient impact in 2024"
